All Stories

  1. A repeat offender: Recurrent extraintestinal Clostridium difficile infection following fecal microbiota transplantation

    Article • Anaerobe, June 2018, Elsevier

    Dr David R Snydman

  2. The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation

    Article • Transplantation, June 2018, Wolters Kluwer Health

    Dr David R Snydman

  3. Antimicrobial susceptibility and ribotypes of Clostridium difficile isolates from a Phase 2 clinical trial of ridinilazole (SMT19969) and vancomycin

    Article • Journal of Antimicrobial Chemotherapy, April 2018, Oxford University Press (OUP)

    Dr David R Snydman

  4. Absolute Lymphocyte Count: A Predictor of Recurrent Cytomegalovirus Disease in Solid Organ Transplant Recipients

    Article • Clinical Infectious Diseases, April 2018, Oxford University Press (OUP)

    Dr David R Snydman

  5. Evaluation of a two-stage testing algorithm for the diagnosis of respiratory viral infections

    Article • Diagnostic Microbiology and Infectious Disease, March 2018, Elsevier

    Dr David R Snydman

  6. Evaluation of theIn VitroActivity of Eravacycline against a Broad Spectrum of Recent Clinical Anaerobic Isolates

    Article • Antimicrobial Agents and Chemotherapy, February 2018, ASM Journals

    Dr David R Snydman

  7. Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, December 2017, New England Journal of Medicine (NEJM/MMS)

    Dr David R Snydman, Dr Francisco M Marty

  8. Lyme disease

    Article • Medicine, December 2017, Elsevier

    Dr David R Snydman

  9. Iron-related markers are associated with infection after liver transplantation

    Article • Liver Transplantation, November 2017, Wiley

    Dr David R Snydman

  10. Role of Secondary Prophylaxis With Valganciclovir in the Prevention of Recurrent Cytomegalovirus Disease in Solid Organ Transplant Recipients

    Article • Clinical Infectious Diseases, August 2017, Oxford University Press (OUP)

    Dr David R Snydman

  11. Selective method for identification and quantification of Bifidobacterium animalis subspecies lactis BB-12 (BB-12) from the gastrointestinal tract of healthy volunteers ingesting a combination probiotic of BB-12 and Lactobacillus rhamnosus GG

    Article • Journal of Applied Microbiology, April 2017, Wiley

    Dr David R Snydman

  12. Trends in antimicrobial resistance among Bacteroides species and Parabacteroides species in the United States from 2010–2012 with comparison to 2008–2009

    Article • Anaerobe, February 2017, Elsevier

    Dr David R Snydman

  13. Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of RG7667, a Combination Monoclonal Antibody, for Prevention of Cytomegalovirus Infection in High-Risk Kidney Transplant Recipients

    Article • Antimicrobial Agents and Chemotherapy, November 2016, ASM Journals

    Dr David R Snydman

  14. Alemtuzumab improves preexisting disability in active relapsing-remitting MS patients

    Article • Neurology, October 2016, Wolters Kluwer Health

    Dr David R Snydman

  15. In VitroEvaluation of the Activity of Imipenem-Relebactam against 451 Recent Clinical Isolates of Bacteroides Group and Related Species

    Article • Antimicrobial Agents and Chemotherapy, August 2016, ASM Journals

    Dr David R Snydman

  16. Increasing Infectious Endocarditis Admissions Among Young People Who Inject Drugs

    Article • Open Forum Infectious Diseases, July 2016, Oxford University Press (OUP)

    Dr David R Snydman

  17. Differences in the Molecular Epidemiology and Antibiotic Susceptibility of Clostridium difficile Isolates in Pediatric and Adult Patients

    Article • Antimicrobial Agents and Chemotherapy, June 2016, ASM Journals

    Dr David R Snydman

  18. Characteristics and outcomes of neutropenia after orthotopic liver transplantation

    Article • Liver Transplantation, January 2016, Wiley

    Dr David R Snydman

  19. Editorial Commentary : Chronic Lung Allograft Dysfunction in Lung Transplant Recipients: Another Piece of the Puzzle

    Article • Clinical Infectious Diseases, November 2015, Oxford University Press (OUP)

    Dr David R Snydman

  20. Physician report cards and rankings yield long-lasting hand hygiene compliance exceeding 90 %

    Article • Critical Care, August 2015, Springer Science + Business Media

    Dr David R Snydman

  21. U.S.-Based National Sentinel Surveillance Study for the Epidemiology of Clostridium difficile-Associated Diarrheal Isolates and Their Susceptibility to Fidaxomicin

    Article • Antimicrobial Agents and Chemotherapy, August 2015, ASM Journals

    Dr David R Snydman

  22. Effect of Lactobacillus rhamnosus GG Administration on Vancomycin-Resistant Enterococcus Colonization in Adults with Comorbidities

    Article • Antimicrobial Agents and Chemotherapy, May 2015, ASM Journals

    Dr Shira Doron, Dr David R Snydman

  23. Risk and Safety of Probiotics

    Article • Clinical Infectious Diseases, April 2015, Oxford University Press (OUP)

    Dr David R Snydman

  24. In vitro evaluation of cytomegalovirus‐specific hyperimmune globulins vs. standard intravenous immunoglobulins

    Article • Vox Sanguinis, March 2015, Wiley

    Dr David R Snydman

  25. No Evidence of Harms of Probiotic Lactobacillus rhamnosus GG ATCC 53103 in Healthy Elderly—A Phase I Open Label Study to Assess Safety, Tolerability and Cytokine Responses

    Article • PLoS ONE, December 2014, PLOS

    Dr David R Snydman

  26. A national survey of infectious disease practitioners on their use of outpatient parenteral antimicrobial therapy (OPAT)

    Article • Infectious Diseases, November 2014, Taylor & Francis

    Dr David R Snydman

  27. Horizontal Infection Control Strategy Decreases Methicillin-Resistant Staphylococcus aureus Infection and Eliminates Bacteremia in a Surgical ICU Without Active Surveillance*

    Article • Critical Care Medicine, October 2014, Wolters Kluwer Health

    Dr David R Snydman

  28. Pretransplant Lymphopenia is a Novel Prognostic Factor in CMV and Non-CMV Invasive Infection After Liver Transplantation

    Article • Liver Transplantation, September 2014, Wiley

    Dr David R Snydman

  29. Carbapenem-resistant enterobacteriaceae: analyzing knowledge and practice in healthcare providers

    Article • PeerJ, May 2014, PeerJ

    Dr David R Snydman

  30. Editorial Commentary: The Complexity of Latent Cytomegalovirus Infection in Stem Cell Donors

    Article • Clinical Infectious Diseases, May 2014, Oxford University Press (OUP)

    Dr David R Snydman

  31. The Efficacy of Daptomycin Versus Vancomycin for Methicillin-Resistant Staphylococcus aureus Bloodstream Infection in Patients With Impaired Renal Function

    Article • Clinical Infectious Diseases, March 2014, Oxford University Press (OUP)

    Dr David R Snydman

  32. Muldoon et al (Clin Infect Dis 2013; 57:419-24)

    Article • Clinical Infectious Diseases, February 2014, Oxford University Press (OUP)

    Dr David R Snydman

  33. Prediction Model for 30-Day Hospital Readmissions Among Patients Discharged Receiving Outpatient Parenteral Antibiotic Therapy

    Article • Clinical Infectious Diseases, December 2013, Oxford University Press (OUP)

    Dr David R Snydman

  34. The impact of cefepime as first line therapy for neutropenic fever on Clostridium difficile rates among hematology and oncology patients

    Article • Anaerobe, December 2013, Elsevier

    Dr David R Snydman

  35. Activity of Ceftolozane-Tazobactam against a Broad Spectrum of Recent Clinical Anaerobic Isolates

    Article • Antimicrobial Agents and Chemotherapy, November 2013, ASM Journals

    Dr David R Snydman

  36. Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, August 2013, New England Journal of Medicine (NEJM/MMS)

    Dr David R Snydman

  37. Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, August 2013, New England Journal of Medicine (NEJM/MMS)

    Dr David R Snydman

  38. Updated International Consensus Guidelines on the Management of Cytomegalovirus in Solid-Organ Transplantation

    Article • Transplantation, August 2013, Wolters Kluwer Health

    Dr David R Snydman, Professor Vincent Emery

  39. Infections in Children and Adolescents With Juvenile Idiopathic Arthritis and Inflammatory Bowel Disease Treated With Tumor Necrosis Factor-  Inhibitors: Systematic Review of the Literature

    Article • Clinical Infectious Diseases, July 2013, Oxford University Press (OUP)

    Dr David R Snydman

  40. Rare and Emerging Viral Infections in Transplant Recipients

    Article • Clinical Infectious Diseases, July 2013, Oxford University Press (OUP)

    Dr David R Snydman

  41. Outpatient parenteral antimicrobial therapy (OPAT) in the republic of Ireland: results of a national survey

    Article • European Journal of Clinical Microbiology & Infectious Diseases, June 2013, Springer Science + Business Media

    Dr David R Snydman

  42. A Nationwide Survey of Antimicrobial Stewardship Practices

    Article • Clinical Therapeutics, June 2013, Elsevier

    Dr David R Snydman

  43. Are We Ready for an Outpatient Parenteral Antimicrobial Therapy Bundle? A Critical Appraisal of the Evidence

    Article • Clinical Infectious Diseases, April 2013, Oxford University Press (OUP)

    Dr David R Snydman

  44. Vancomycin-ResistantEnterococcusInfections in Solid Organ Transplantation

    Article • American Journal of Transplantation, March 2013, Wiley

    Dr David R Snydman

  45. Neutropenic Enterocolitis, a Growing Concern in the Era of Widespread Use of Aggressive Chemotherapy

    Article • Clinical Infectious Diseases, November 2012, Oxford University Press (OUP)

    Dr David R Snydman

  46. Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial

    Article • The Lancet, November 2012, Elsevier

    Dr David R Snydman

  47. Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial

    Article • The Lancet, November 2012, Elsevier

    Dr David R Snydman

  48. State-of-the-Art Monitoring of Cytomegalovirus-Specific Cell-Mediated Immunity After Organ Transplant: A Primer for the Clinician

    Article • Clinical Infectious Diseases, September 2012, Oxford University Press (OUP)

    Dr David R Snydman

  49. First report of a left ventricular assist device infection caused by Staphylococcus schleiferi subspecies coagulans: a coagulase-positive organism

    Article • Diagnostic Microbiology and Infectious Disease, September 2012, Elsevier

    Dr David R Snydman

  50. Carbapenem-Resistant Enterobacteriaceae: A Statewide Survey of Detection in Massachusetts Hospitals

    Article • Infection Control and Hospital Epidemiology, September 2012, Cambridge University Press

    Dr David R Snydman

  51. Transmission of Infection With Human Allografts: Essential Considerations in Donor Screening

    Article • Clinical Infectious Diseases, June 2012, Oxford University Press (OUP)

    Dr David R Snydman

  52. Nosocomial Hepatitis C: More of a Hidden Epidemic

    Article • Annals of Internal Medicine, April 2012, American College of Physicians

    Dr David R Snydman

  53. Activity of a Novel Cyclic Lipopeptide, CB-183,315, against Resistant Clostridium difficile and Other Gram-Positive Aerobic and Anaerobic Intestinal Pathogens

    Article • Antimicrobial Agents and Chemotherapy, March 2012, ASM Journals

    Dr David R Snydman

  54. Empiric antibiotic selection strategies for healthcare-associated pneumonia, intra-abdominal infections, and catheter-associated bacteremia

    Article • Journal of Hospital Medicine, January 2012, Frontline Medical Communications, Inc.

    Dr David R Snydman

  55. Reply to van Hal et al

    Article • Clinical Infectious Diseases, October 2011, Oxford University Press (OUP)

    Dr David R Snydman

  56. Update on resistance of Bacteroides fragilis group and related species with special attention to carbapenems 2006–2009

    Article • Anaerobe, August 2011, Elsevier

    Dr David R Snydman

  57. High Incidence of Herpes Zoster in Nonmyeloablative Hematopoietic Stem Cell Transplantation

    Article • Biology of Blood and Marrow Transplantation, July 2011, Elsevier

    Dr David R Snydman

  58. Persistent babesiosis in a stem cell transplant recipient

    Article • Leukemia Research, June 2011, Elsevier

    Dr David R Snydman

  59. The impact of CMV prevention on long-term recipient and graft survival in heart transplant recipients: analysis of the Scientific Registry of Transplant Recipients (SRTR) database

    Article • Clinical Transplantation, April 2011, Wiley

    Dr David R Snydman

  60. Why did maribavir fail in stem-cell transplants?

    Article • The Lancet Infectious Diseases, April 2011, Elsevier

    Dr David R Snydman

  61. Update and Review: State-of-the-Art Management of Cytomegalovirus Infection and Disease Following Thoracic Organ Transplantation

    Article • Transplantation Proceedings, April 2011, Elsevier

    Dr David R Snydman

  62. Predicting High Vancomycin Minimum Inhibitory Concentration in Methicillin-Resistant Staphylococcus aureus Bloodstream Infections

    Article • Clinical Infectious Diseases, April 2011, Oxford University Press (OUP)

    Dr David R Snydman

  63. Lactobacillus GG as an immune adjuvant for live-attenuated influenza vaccine in healthy adults: a randomized double-blind placebo-controlled trial

    Article • European Journal of Clinical Nutrition, February 2011, Springer Science + Business Media

    Dr David R Snydman

  64. Putting the IMPACT Study into Perspective: Should CMV Prophylaxis Be Extended to 6 Months for High Risk Transplants?

    Article • American Journal of Transplantation, December 2010, Wiley

    Dr David R Snydman

  65. Cytomegalovirus Prevention and Long-Term Recipient and Graft Survival in Pediatric Heart Transplant Recipients

    Article • Transplantation, December 2010, Wolters Kluwer Health

    Dr David R Snydman

  66. In VitroActivity of Ceftaroline against a Broad Spectrum of Recent Clinical Anaerobic Isolates

    Article • Antimicrobial Agents and Chemotherapy, November 2010, ASM Journals

    Dr David R Snydman

  67. Leflunomide: A Small Step Forward in Meeting the Urgent Need for Treatment of Drug-Resistant Cytomegalovirus Infection

    Article • Transplantation, August 2010, Wolters Kluwer Health

    Dr David R Snydman

  68. Increased Serum Iron Levels and Infectious Complications after Liver Transplantation

    Article • Clinical Infectious Diseases, August 2010, Oxford University Press (OUP)

    Dr David R Snydman

  69. Blood stream infection (BSI) and acute GVHD after hematopoietic SCT (HSCT) are associated

    Article • Bone Marrow Transplantation, May 2010, Springer Science + Business Media

    Dr David R Snydman

  70. A randomized, double-blind, placebo-controlled trial of valacyclovir prophylaxis to prevent zoster recurrence from months 4 to 24 after BMT

    Article • Bone Marrow Transplantation, April 2010, Springer Science + Business Media

    Dr David R Snydman

  71. International Consensus Guidelines on the Management of Cytomegalovirus in Solid Organ Transplantation

    Article • Transplantation, April 2010, Wolters Kluwer Health

    Dr David R Snydman, Professor Vincent Emery

  72. Evaluation of Vancomycin and Daptomycin Potency Trends (MIC Creep) against Methicillin-Resistant Staphylococcus aureus Isolates Collected in Nine U.S. Medical Centers from 2002 to 2006

    Article • Antimicrobial Agents and Chemotherapy, March 2010, ASM Journals

    Dr David R Snydman

  73. Donor Screening for Human T-cell Lymphotrophic Virus 1/2: Changing Paradigms for Changing Testing Capacity

    Article • American Journal of Transplantation, February 2010, Wiley

    Dr David R Snydman

  74. Introduction

    Article • Clinical Infectious Diseases, February 2010, Oxford University Press (OUP)

    Dr David R Snydman

  75. Lessons Learned from the Anaerobe Survey: Historical Perspective and Review of the Most Recent Data (2005–2007)

    Article • Clinical Infectious Diseases, January 2010, Oxford University Press (OUP)

    Dr David R Snydman

  76. Cytomegalovirus in Solid Organ Transplant Recipients

    Article • American Journal of Transplantation, December 2009, Wiley

    Dr David R Snydman

  77. Severity of illness scoring systems in patients with bacteraemic pneumococcal pneumonia: implications for the intensive care unit care

    Article • Clinical Microbiology and Infection, September 2009, Elsevier

    Dr David R Snydman

  78. Evaluation of Vancomycin and Daptomycin Potency Trends (MIC Creep) against Methicillin-Resistant Staphylococcus aureus Isolates Collected in Nine U.S. Medical Centers from 2002 to 2006

    Article • Antimicrobial Agents and Chemotherapy, July 2009, ASM Journals

    Dr David R Snydman

  79. Cytomegalovirus Prevention Strategies: The Case for Prophylaxis

    Article • American Journal of Transplantation, May 2009, Wiley

    Dr David R Snydman

  80. Risk factors for death after sepsis in patients immunosuppressed before the onset of sepsis

    Article • Scandinavian Journal of Infectious Diseases, January 2009, Taylor & Francis

    Dr David R Snydman

  81. In Vitro Activities of Doripenem, a New Broad-Spectrum Carbapenem, against Recently Collected Clinical Anaerobic Isolates, with Emphasis on the Bacteroides fragilis Group

    Article • Antimicrobial Agents and Chemotherapy, October 2008, ASM Journals

    Dr David R Snydman

  82. Editorial Commentary: Persistent Clinical Impact of Cytomegalovirus in Organ Transplantation

    Article • Clinical Infectious Diseases, October 2008, Oxford University Press (OUP)

    Dr David R Snydman

  83. Antibiotic Exposure and Room Contamination Among Patients Colonized With Vancomycin-Resistant Enterococci

    Article • Infection Control and Hospital Epidemiology, August 2008, Cambridge University Press

    Dr David R Snydman, Professor Christopher H Schmid

  84. Destruction of Isolates from the Pittsburgh Veterans Affairs Laboratory

    Article • Clinical Infectious Diseases, April 2008, Oxford University Press (OUP)

    Dr David R Snydman

  85. Prior Environmental Contamination Increases the Risk of Acquisition of Vancomycin-Resistant Enterococci

    Article • Clinical Infectious Diseases, March 2008, Oxford University Press (OUP)

    Dr David R Snydman, Professor Christopher H Schmid

  86. The Safety of Probiotics

    Article • Clinical Infectious Diseases, February 2008, Oxford University Press (OUP)

    Dr David R Snydman

  87. Repeated enzyme immunoassays have limited utility in diagnosing Clostridium difficile

    Article • European Journal of Clinical Microbiology & Infectious Diseases, January 2008, Springer Science + Business Media

    Dr David R Snydman

  88. Use of Valganciclovir for Prevention and Treatment of Cytomegalovirus Disease

    Article • Clinical Infectious Diseases, January 2008, Oxford University Press (OUP)

    Dr David R Snydman

  89. Prophylaxis and treatment of cytomegalovirus disease in recipients of solid organ transplants: current approach and future challenges

    Article • Current Opinion in Infectious Diseases, August 2007, Wolters Kluwer Health

    Dr David R Snydman

  90. Daptomycin in the treatment of vancomycin-resistant Enterococcus faecium bacteremia in neutropenic patients

    Article • Journal of Infection, June 2007, Elsevier

    Dr David R Snydman

  91. Prevention of Catheter-Related Bloodstream Infections: Looking to the Department of Veterans Affairs Health Care System for Guidance

    Article • Mayo Clinic Proceedings, June 2007, Elsevier

    Dr David R Snydman

  92. Blood stream infection after hematopoietic stem cell transplantation is associated with increased mortality

    Article • Bone Marrow Transplantation, April 2007, Springer Science + Business Media

    Dr David R Snydman

  93. National Survey on the Susceptibility of Bacteroides fragilis Group: Report and Analysis of Trends in the United States from 1997 to 2004

    Article • Antimicrobial Agents and Chemotherapy, February 2007, ASM Journals

    Dr David R Snydman

  94. Preventing Post–Organ Transplantation Cytomegalovirus Disease with Ganciclovir: A Meta‐Analysis Comparing Prophylactic and Preemptive Therapies

    Article • Clinical Infectious Diseases, October 2006, Oxford University Press (OUP)

    Dr David R Snydman

  95. Prevention of Catheter and Intravascular Device-Related Infections: A Quality-of-Care Mandate for Institutions and Physicians

    Article • Mayo Clinic Proceedings, September 2006, Elsevier

    Dr David R Snydman

  96. Endocarditis and pericarditis complicating pneumococcal bacteraemia, with special reference to the adhesive abilities of pneumococci: results from a prospective study

    Article • Clinical Microbiology and Infection, April 2006, Elsevier

    Dr David R Snydman

  97. Hypogammaglobulinemia in Liver Transplant Recipients: Incidence, Timing, Risk Factors, and Outcomes

    Article • Transplantation, March 2006, Wolters Kluwer Health

    Dr David R Snydman

  98. Multicenter Evaluation of the In Vitro Susceptibility of Staphylococci to Vancomycin

    Article • Infectious Diseases in Clinical Practice, March 2006, Wolters Kluwer Health

    Dr David R Snydman

  99. The Impact of Gown-Use Requirement on Hand Hygiene Compliance

    Article • Clinical Infectious Diseases, February 2006, Oxford University Press (OUP)

    Dr David R Snydman

  100. The potential role for iron overload and fungal infection in liver transplantation

    Article • Liver Transplantation, January 2006, Wiley

    Dr David R Snydman

  101. The case for cytomegalovirus prophylaxis in solid organ transplantation

    Article • Reviews in Medical Virology, January 2006, Wiley

    Dr David R Snydman

  102. Lactobacillus GG: Bacteriology and Clinical Applications

    Article • Gastroenterology Clinics of North America, September 2005, Elsevier

    Dr David R Snydman

  103. Fluconazole MIC and the Fluconazole Dose/MIC Ratio Correlate with Therapeutic Response among Patients with Candidemia

    Article • Antimicrobial Agents and Chemotherapy, August 2005, ASM Journals

    Dr David R Snydman

  104. The Clinical Relevance and Correct Designation of Isolates Nonsusceptible to Daptomycin

    Article • Clinical Infectious Diseases, August 2005, Oxford University Press (OUP)

    Dr David R Snydman

  105. Transmission of Vancomycin-Resistant Enterococcus in a Neonatal Intensive Care Unit

    Article • The Pediatric Infectious Disease Journal, June 2005, Wolters Kluwer Health

    Dr David R Snydman

  106. Evaluation of the in vitro activity of NVP-LMB415 against clinical anaerobic isolates with emphasis on the Bacteroides fragilis group

    Article • Journal of Antimicrobial Chemotherapy, April 2005, Oxford University Press (OUP)

    Dr David R Snydman

  107. Daptomycin‐Resistant, Methicillin‐Resistant Staphylococcus aureus Bacteremia

    Article • Clinical Infectious Diseases, April 2005, Oxford University Press (OUP)

    Dr David R Snydman, Professor Davidson Howes Hamer

  108. Counterpoint: Prevention of Cytomegalovirus (CMV) Infection and CMV Disease in Recipients of Solid Organ Transplants: The Case for Prophylaxis

    Article • Clinical Infectious Diseases, March 2005, Oxford University Press (OUP)

    Dr David R Snydman

  109. Impact of cytomegalovirus prophylaxis on rejection following orthotopic liver transplantation

    Article • Liver Transplantation, January 2005, Wiley

    Dr David R Snydman

  110. The Clinical Impact of Ganciclovir Prophylaxis on the Occurrence of Bacteremia in Orthotopic Liver Transplant Recipients

    Article • Clinical Infectious Diseases, November 2004, Oxford University Press (OUP)

    Dr David R Snydman

  111. Combination Antibiotic Therapy Lowers Mortality among Severely Ill Patients with Pneumococcal Bacteremia

    Article • American Journal of Respiratory and Critical Care Medicine, August 2004, American Thoracic Society

    Dr David R Snydman

  112. Iron storage indices and risk of bacterial infections in hemodialysis patients

    Article • Hemodialysis International, July 2004, Wiley

    Dr David R Snydman

  113. Intra-abdominal infections: review of the bacteriology, antimicrobial susceptibility and the role of ertapenem in their therapy

    Article • Journal of Antimicrobial Chemotherapy, May 2004, Oxford University Press (OUP)

    Dr David R Snydman

  114. Iron Storage Indices: Novel Predictors of Bacteremia in Hemodialysis Patients Initiating Intravenous Iron Therapy

    Article • Clinical Infectious Diseases, April 2004, Oxford University Press (OUP)

    Dr David R Snydman

  115. In Vitro Activities of Tigecycline against the Bacteroides fragilis Group

    Article • Antimicrobial Agents and Chemotherapy, March 2004, ASM Journals

    Dr David R Snydman

  116. Viral Prophylaxis in Organ Transplant Patients

    Article • Drugs, January 2004, Springer Science + Business Media

    Dr David R Snydman

  117. Relationship of pulmonary artery catheter use to mortality and resource utilization in patients with severe sepsis*

    Article • Critical Care Medicine, December 2003, Wolters Kluwer Health

    Dr David R Snydman

  118. Vancomycin-resistant enterococcal infections: Cause for concern?

    Article • Liver Transplantation, November 2003, Wiley

    Dr David R Snydman

  119. Role of Environmental Contamination as a Risk Factor for Acquisition of Vancomycin-Resistant Enterococci in Patients Treated in a Medical Intensive Care Unit

    Article • Archives of Internal Medicine, September 2003, American Medical Association (AMA)

    Dr David R Snydman

  120. An International Prospective Study of Pneumococcal Bacteremia: Correlation with In Vitro Resistance, Antibiotics Administered, and Clinical Outcome

    Article • Clinical Infectious Diseases, July 2003, Oxford University Press (OUP)

    Dr David R Snydman

  121. Emergence of fluoroquinolone resistance among Bacteroides species

    Article • Journal of Antimicrobial Chemotherapy, July 2003, Oxford University Press (OUP)

    Dr David R Snydman

  122. Shifting Patterns in the Epidemiology of Nosocomial Candida Infections*

    Article • CHEST Journal, May 2003, Elsevier

    Dr David R Snydman

  123. Randomized Comparison of Oral Valacyclovir and Intravenous Ganciclovir for Prevention of Cytomegalovirus Disease after Allogeneic Bone Marrow Transplantation

    Article • Clinical Infectious Diseases, March 2003, Oxford University Press (OUP)

    Dr David R Snydman

  124. Reduced Acquisition of Vancomycin‐Resistant Enterococci: Gown Effect or Confounding?

    Article • Clinical Infectious Diseases, February 2003, Oxford University Press (OUP)

    Dr David R Snydman

  125. In Vitro Activities of Newer Quinolones against Bacteroides Group Organisms

    Article • Antimicrobial Agents and Chemotherapy, February 2003, ASM Journals

    Dr David R Snydman

  126. Article • Critical Care, January 2003, Springer Science + Business Media

    Dr David R Snydman

  127. Resource Utilization Among Patients With Sepsis Syndrome

    Article • Infection Control and Hospital Epidemiology, January 2003, Cambridge University Press

    Dr David R Snydman

  128. In Vitro Activities of Newer Quinolones against Bacteroides Group Organisms

    Article • Antimicrobial Agents and Chemotherapy, October 2002, ASM Journals

    Dr David R Snydman

  129. National Survey on the Susceptibility of Bacteroides fragilis Group: Report and Analysis of Trends for 1997–2000

    Article • Clinical Infectious Diseases, September 2002, Oxford University Press (OUP)

    Dr David R Snydman

  130. Association between the Presence of Enterococcal Virulence Factors Gelatinase, Hemolysin, and Enterococcal Surface Protein and Mortality among Patients with Bacteremia Due to Enterococcus faecalis

    Article • Clinical Infectious Diseases, September 2002, Oxford University Press (OUP)

    Dr David R Snydman

  131. Attributable Mortality of Stenotrophomonas maltophilia Bacteremia

    Article • Clinical Infectious Diseases, June 2002, Oxford University Press (OUP)

    Dr David R Snydman

  132. Real-time antifungal susceptibility screening aids management of invasive yeast infections in immunocompromised patients

    Article • Journal of Antimicrobial Chemotherapy, February 2002, Oxford University Press (OUP)

    Dr David R Snydman

  133. GB Virus C and Mortality from HIV Infection

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, January 2002, New England Journal of Medicine (NEJM/MMS)

    Dr David R Snydman

  134. Clinical utility of blood cultures drawn from central venous or arterial catheters in critically ill surgical patients

    Article • Critical Care Medicine, January 2002, Wolters Kluwer Health

    Dr David R Snydman

  135. Historical overview of the use of cytomegalovirus hyperimmune globulin in organ transplantation

    Article • Transplant Infectious Disease, December 2001, Wiley

    Dr David R Snydman

  136. Association of Human Herpesvirus 6 Reactivation with Severe Cytomegalovirus‐Associated Disease in Orthotopic Liver Transplant Recipients

    Article • Clinical Infectious Diseases, October 2001, Oxford University Press (OUP)

    Dr David R Snydman

  137. Determinants of Vancomycin Resistance and Mortality Rates in Enterococcal Bacteremia: A Prospective Multicenter Study

    Article • Annals of Internal Medicine, October 2001, American College of Physicians

    Dr David R Snydman

  138. Late and Atypical Cytomegalovirus Disease in Solid‐Organ Transplant Recipients

    Article • Clinical Infectious Diseases, October 2001, Oxford University Press (OUP)

    Dr David R Snydman

  139. Posttransplant Microbiological Surveillance

    Article • Clinical Infectious Diseases, July 2001, Oxford University Press (OUP)

    Dr David R Snydman

  140. Epidemiology of Infections after Solid‐Organ Transplantation

    Article • Clinical Infectious Diseases, July 2001, Oxford University Press (OUP)

    Dr David R Snydman

  141. Use of combination cytomegalovirus immune globulin plus ganciclovir for prophylaxis in CMV-seronegative liver transplant recipients of a CMV-seropositive donor organ: a multicenter, open-label study

    Article • Transplantation Proceedings, June 2001, Elsevier

    Dr David R Snydman

  142. Daptomycin for line-related Leuconostoc bacteraemia

    Article • Journal of Antimicrobial Chemotherapy, March 2001, Oxford University Press (OUP)

    Dr David R Snydman

  143. Increasing Mortality Due to End-Stage Liver Disease in Patients with Human Immunodeficiency Virus Infection

    Article • Clinical Infectious Diseases, February 2001, Oxford University Press (OUP)

    Dr David R Snydman

  144. Comparative In Vitro Activities of Daptomycin and Vancomycin against Resistant Gram-Positive Pathogens

    Article • Antimicrobial Agents and Chemotherapy, December 2000, ASM Journals

    Dr David R Snydman

  145. Clinical Manifestations and Molecular Epidemiology of Late Recurrent Candidemia, and Implications for Management

    Article • European Journal of Clinical Microbiology & Infectious Diseases, September 2000, Springer Science + Business Media

    Dr David R Snydman

  146. Comparative In Vitro Activities of Clinafloxacin and Trovafloxacin against 1,000 Isolates of Bacteroides fragilisGroup: Effect of the Medium on Test Results

    Article • Antimicrobial Agents and Chemotherapy, June 2000, ASM Journals

    Dr David R Snydman

  147. Antimicrobial Resistance and Clinical Outcome of Bacteroides Bacteremia: Findings of a Multicenter Prospective Observational Trial

    Article • Clinical Infectious Diseases, June 2000, Oxford University Press (OUP)

    Dr David R Snydman

  148. Cytomegalovirus immune globulin after liver transplantation: a cost-effectiveness analysis 1

    Article • Clinical Transplantation, February 2000, Wiley

    Dr David R Snydman, Professor Christopher H Schmid

  149. Varicella zoster virus infections following allogeneic bone marrow transplantation: Frequency, risk factors, and clinical outcome

    Article • Biology of Blood and Marrow Transplantation, January 2000, Elsevier

    Dr David R Snydman

  150. Clinical Utility of Blood Cultures Drawn from Indwelling Central Venous Catheters in Hospitalized Patients with Cancer

    Article • Annals of Internal Medicine, November 1999, American College of Physicians

    Dr David R Snydman

  151. OUTCOME OF TRANSPLANTATION OF ORGANS PROCURED FROM BACTEREMIC DONORS1

    Article • Transplantation, October 1999, Wolters Kluwer Health

    Dr David R Snydman

  152. Infection in solid organ transplantation

    Article • Transplant Infectious Disease, March 1999, Wiley

    Dr David R Snydman

  153. Human Herpesvirus 6 Reactivation Is Associated with Cytomegalovirus Infection and Syndromes in Kidney Transplant Recipients at Risk for Primary Cytomegalovirus Infection

    Article • The Journal of Infectious Diseases, December 1998, Oxford University Press (OUP)

    Dr David R Snydman

  154. Utility of Serial Rectal Swab Cultures for Detection of Ceftazidime- and Imipenem-Resistant Gram-Negative Bacilli from Patients in the Intensive Care Unit

    Article • European Journal of Clinical Microbiology & Infectious Diseases, November 1998, Springer Science + Business Media

    Dr David R Snydman

  155. SIGNIFICANCE OF CYTOMEGALOVIRUS FOR LONG-TERM SURVIVAL AFTER ORTHOTOPIC LIVER TRANSPLANTATION

    Article • Transplantation, October 1998, Wolters Kluwer Health

    Dr David R Snydman

  156. Limulus Amebocyte Lysate Assay for Detection of Endotoxin in Patients with Sepsis Syndrome

    Article • Clinical Infectious Diseases, September 1998, Oxford University Press (OUP)

    Dr David R Snydman

  157. Vaccine-Associated Measles Pneumonitis in an Adult with AIDS

    Article • Annals of Internal Medicine, July 1998, American College of Physicians

    Dr David R Snydman

  158. Vancomycin-resistant enterococcal infections in bone marrow transplant recipients

    Article • Bone Marrow Transplantation, July 1998, Springer Science + Business Media

    Dr David R Snydman

  159. ORGAN DONOR SCREENING FOR INFECTIOUS DISEASES

    Article • Transplantation, March 1998, Wolters Kluwer Health

    Dr David R Snydman

  160. Infective Endocarditis in Solid Organ Transplant Recipients

    Article • Clinical Infectious Diseases, March 1998, Oxford University Press (OUP)

    Dr David R Snydman

  161. Late Incidence of Cancer After Metronidazole Use: A Matched Metronidazole User/Nonuser Study

    Article • Clinical Infectious Diseases, February 1998, Oxford University Press (OUP)

    Dr David R Snydman

  162. Adenovirus Infection in Adult Orthotopic Liver Transplant Recipients: Incidence and Clinical Significance

    Article • The Journal of Infectious Diseases, February 1998, Oxford University Press (OUP)

    Dr David R Snydman

  163. Antiviral Immunotherapy

    Article • BioDrugs, January 1998, Springer Science + Business Media

    Dr David R Snydman

  164. The Independent Role of Cytomegalovirus as a Risk Factor for Invasive Fungal Disease in Orthotopic Liver Transplant Recipients

    Article • The American Journal of Medicine, August 1997, Elsevier

    Dr David R Snydman

  165. Clinical and Epidemiological Predictors of Recurrent Cytomegalovirus Disease in Orthotopic Liver Transplant Recipients

    Article • Clinical Infectious Diseases, August 1997, Oxford University Press (OUP)

    Dr David R Snydman

  166. Epidemiology of sepsis syndrome in 8 academic medical centers. Academic Medical Center Consortium Sepsis Project Working Group

    Article • JAMA, July 1997, American Medical Association (AMA)

    Dr David R Snydman

  167. CYTOMEGALOVIRUS DISEASE IS ASSOCIATED WITH INCREASED COST AND HOSPITAL LENGTH OF STAY AMONG ORTHOTOPIC LIVER TRANSPLANT RECIPIENTS1

    Article • Transplantation, June 1997, Wolters Kluwer Health

    Dr David R Snydman

  168. Effect of Cytomegalovirus Infection Status on First-Year Mortality Rates among Orthotopic Liver Transplant Recipients

    Article • Annals of Internal Medicine, February 1997, American College of Physicians

    Dr David R Snydman

  169. Predicting Clostridium difficile Stool Cytotoxin Results in Hospitalized Patients with Diarrhea

    Article • Journal of General Internal Medicine, January 1997, Springer Science + Business Media

    Dr David R Snydman

  170. Predicting Clostridium difficile Stool Cytotoxin Results in Hospitalized Patients with Diarrhea

    Article • Journal of General Internal Medicine, January 1997, Springer Science + Business Media

    Dr David R Snydman

  171. Risk factors leading to clinical failure in the treatment of intra-abdominal or skin/soft tissue infections

    Article • European Journal of Clinical Microbiology & Infectious Diseases, December 1996, Springer Science + Business Media

    Dr David R Snydman

  172. The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance

    Article • The American Journal of Medicine, June 1996, Elsevier

    Dr David R Snydman

  173. INCIDENCE AND PREDICTORS OF CYTOMEGALOVIRUS PNEUMONIA IN ORTHOTOPIC LIVER TRANSPLANT RECIPIENTS1

    Article • Transplantation, June 1996, Wolters Kluwer Health

    Dr David R Snydman

  174. CYTOMEGALOVIRUS PROPHYLAXIS IN SOLID ORGAN TRANSPLANT RECIPIENTS

    Article • Transplantation, May 1996, Wolters Kluwer Health

    Dr David R Snydman

  175. Prevention of cytomegalovirus disease in transplant recipients

    Article • The Lancet, January 1996, Elsevier

    Dr David R Snydman

  176. Therapeutic approaches in patients with candidemia. Evaluation in a multicenter, prospective, observational study

    Article • Archives of Internal Medicine, December 1995, American Medical Association (AMA)

    Dr David R Snydman

  177. Therapeutic Approaches in Patients With Candidemia

    Article • Archives of Internal Medicine, December 1995, American Medical Association (AMA)

    Dr David R Snydman

  178. Spectrum and Significance of Bacteremia Due to Moraxella catarrhalis

    Article • Clinical Infectious Diseases, August 1995, Oxford University Press (OUP)

    Dr David R Snydman

  179. Preemptive Ganciclovir Therapy To Prevent Cytomegalovirus Disease in Cytomegalovirus Antibody-Positive Renal Transplant Recipients

    Article • Annals of Internal Medicine, July 1995, American College of Physicians

    Dr David R Snydman

  180. Attributable Mortality of Bacteremia Associated with the Bacteroides fragilis Group

    Article • Clinical Infectious Diseases, June 1995, Oxford University Press (OUP)

    Dr David R Snydman

  181. Aspergillus fumigatus Infection of a Biloma

    Article • Clinical Infectious Diseases, May 1995, Oxford University Press (OUP)

    Dr David R Snydman

  182. Treatment of Severe Pneumonia in Hospitalised Patients

    Article • Drugs, January 1995, Springer Science + Business Media

    Dr David R Snydman

  183. Influence of Blood Culture Results on Antibiotic Choice in the Treatment of Bacteremia

    Article • Archives of Internal Medicine, December 1994, American Medical Association (AMA)

    Dr David R Snydman

  184. Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. The Severe Pneumonia Study Group.

    Article • Antimicrobial Agents and Chemotherapy, March 1994, ASM Journals

    Dr David R Snydman

  185. Cytomegalovirus Immune Globulin Prophylaxis in Liver Transplantation

    Article • Annals of Internal Medicine, November 1993, American College of Physicians

    Dr David R Snydman

  186. Controlled trial to evaluate protection of high-risk infants against respiratory syncytial virus disease by using standard intravenous immune globulin.

    Article • Antimicrobial Agents and Chemotherapy, August 1993, ASM Journals

    Dr David R Snydman

  187. New Developments in Cytomegalovirus Prevention and Management

    Article • American Journal of Kidney Diseases, February 1993, Elsevier

    Dr David R Snydman

  188. Correlation of various in vitro testing methods with clinical outcomes in patients with Bacteroides fragilis group infections treated with cefoxitin: a retrospective analysis.

    Article • Antimicrobial Agents and Chemotherapy, March 1992, ASM Journals

    Dr David R Snydman

  189. The risk of cytomegalovirus infection in solid organ and bone marrow transplant recipients: transfusion of blood products

    Article • Transfusion, September 1990, Wiley

    Dr David R Snydman

  190. Cytomegalovirus Immunoglobulins in the Prevention and Treatment of Cytomegalovirus Disease

    Article • Clinical Infectious Diseases, September 1990, Oxford University Press (OUP)

    Dr David R Snydman

  191. Capnocytophaga infection involving a portal-systemic vascular shunt

    Article • Digestive Diseases and Sciences, July 1990, Springer Science + Business Media

    Dr David R Snydman

  192. Cytomegalovirus infection in solid organ transplantation: Prospects for prevention

    Article • Transplantation Reviews, July 1990, Elsevier

    Dr David R Snydman

  193. An Outbreak of Hepatitis A among Cancer Patients Treated with Interleukin-2 and Lymphokine-Activated Killer Cells

    Article • The Journal of Infectious Diseases, April 1990, Oxford University Press (OUP)

    Dr David R Snydman

  194. Nosocomial Sepsis Associated with Interleukin-2

    Article • Annals of Internal Medicine, January 1990, American College of Physicians

    Dr David R Snydman

  195. The antimicrobial susceptibility patterns of the Barteroides fragilis group in the United States, 1987

    Article • Journal of Antimicrobial Chemotherapy, January 1990, Oxford University Press (OUP)

    Dr David R Snydman

  196. Nosocomial Branhamella catarrhalis in a paediatric intensive care unit: Risk factors for disease

    Article • Journal of Hospital Infection, April 1989, Elsevier

    Dr David R Snydman

  197. Ganciclovir Therapy for Cytomegalovirus Disease Associated with Renal Transplants

    Article • Clinical Infectious Diseases, July 1988, Oxford University Press (OUP)

    Dr David R Snydman

  198. Prevention of Nosocomial Transmission of Respiratory Syncytial Virus in a Newborn Nursery

    Article • Infection Control and Hospital Epidemiology, March 1988, Cambridge University Press

    Dr David R Snydman

  199. Ganciclovir for Treatment of Renal Transplant-Associated Primary Cytomegalovirus Pneumonia

    Article • The Journal of Infectious Diseases, January 1988, Oxford University Press (OUP)

    Dr David R Snydman

  200. Use of Cytomegalovirus Immune Globulin to Prevent Cytomegalovirus Disease in Renal-Transplant Recipients

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, October 1987, New England Journal of Medicine (NEJM/MMS)

    Dr David R Snydman

  201. Clinical importance of cefoxitin-resistant Bacteroides fragilis isolates

    Article • Diagnostic Microbiology and Infectious Disease, June 1987, Elsevier

    Dr David R Snydman

  202. Borrelia burgdorferi in Joint Fluid in Chronic Lyme Arthritis

    Article • Annals of Internal Medicine, June 1986, American College of Physicians

    Dr David R Snydman

  203. Hepatitis in Pregnancy

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, November 1985, New England Journal of Medicine (NEJM/MMS)

    Dr David R Snydman

  204. Absence of antibodies to HTLV-III in health workers after hepatitis B vaccination

    Article • JAMA, August 1985, American Medical Association (AMA)

    Dr David R Snydman

  205. Absence of Antibodies to HTLV-III in Health Workers After Hepatitis B Vaccination

    Article • JAMA, August 1985, American Medical Association (AMA)

    Dr David R Snydman

  206. Isolated Antibody to Hepatitis B Surface Antigen and Response to Hepatitis B Vaccination

    Article • Annals of Internal Medicine, August 1985, American College of Physicians

    Dr David R Snydman

  207. Changing Intravenous Tubing Containing Burettes-Reply

    Article • JAMA, January 1985, American Medical Association (AMA)

    Dr David R Snydman

  208. Capnocytophaga Species: Infections in Nonimmunocompromised and Immunocompromised Hosts

    Article • The Journal of Infectious Diseases, January 1985, Oxford University Press (OUP)

    Dr David R Snydman

  209. Ocular and pericardial involvement in Legionnaires' disease

    Article • The American Journal of Medicine, December 1984, Elsevier

    Dr David R Snydman

  210. Hepatitis B Vaccine in Health Care Personnel: Safety, lmmunogenicity, and Indicators of Efficacy

    Article • Annals of Internal Medicine, July 1984, American College of Physicians

    Dr David R Snydman

  211. Acquired Immunodeficiency Syndrome with Progressive Multifocal Leukoencephalopathy and Monoclonal B-Cell Proliferation

    Article • Annals of Internal Medicine, May 1984, American College of Physicians

    Dr David R Snydman

  212. A simultaneous outbreak of respiratory syncytial virus and parainfluenza virus type 3 in a newborn nursery

    Article • The Journal of Pediatrics, May 1984, Elsevier

    Dr David R Snydman

  213. Intravenous tubing with burettes can be safely changed at 48-hour intervals

    Article • JAMA, April 1984, American Medical Association (AMA)

    Dr David R Snydman

  214. Intravenous Tubing With Burettes Can Be Safely Changed at 48-Hour Intervals

    Article • JAMA, April 1984, American Medical Association (AMA)

    Dr David R Snydman

  215. Hemophilus aphrophilus osteomyelitis

    Article • The American Journal of Medicine, January 1984, Elsevier

    Dr David R Snydman

  216. Prevention of Cytomegalovirus Infection by Cytomegalovirus Immune Globulin After Marrow Transplantation

    Article • Annals of Internal Medicine, April 1983, American College of Physicians

    Dr David R Snydman

  217. BACTERIA IN TOTAL PARENTERAL NUTRITION CATHETERS

    Article • The Lancet, April 1983, Elsevier

    Dr David R Snydman

  218. PREDICTIVE VALUE OF SURVEILLANCE SKIN CULTURES IN TOTAL-PARENTERAL-NUTRITION-RELATED INFECTION

    Article • The Lancet, December 1982, Elsevier

    Dr David R Snydman

  219. Total parenteral nutrition-related infections

    Article • The American Journal of Medicine, November 1982, Elsevier

    Dr David R Snydman

  220. Infectious Mononucleosis in an Adult Progressing to Fatal lmmunoblastic Lymphoma

    Article • Annals of Internal Medicine, June 1982, American College of Physicians

    Dr David R Snydman

  221. Use of IgM-hepatitis A antibody testing. Investigating a common-source, food borne outbreak

    Article • JAMA, February 1981, American Medical Association (AMA)

    Dr David R Snydman

  222. Use of IgM-Hepatitis A Antibody Testing

    Article • JAMA, February 1981, American Medical Association (AMA)

    Dr David R Snydman

  223. Clinical trial of piperacillin with acquisition of resistance by Pseudomonas and clinical relapse.

    Article • Antimicrobial Agents and Chemotherapy, July 1980, ASM Journals

    Dr David R Snydman

  224. Bacteroides bivius and Bacteroides disiens in obstetrical patients: clinical findings and antimicrobial susceptibilities

    Article • Journal of Antimicrobial Chemotherapy, January 1980, Oxford University Press (OUP)

    Dr David R Snydman

  225. Antiviral Agents

    Article • Drugs, November 1979, Springer Science + Business Media

    Dr David R Snydman

  226. Netilmicin in Gram-Negative Bacterial Infections

    Article • Antimicrobial Agents and Chemotherapy, January 1979, ASM Journals

    Dr David R Snydman

  227. Plasmid-Mediated, Transferable Resistance to Clindamycin and Erythromycin in Bacteroides fragilis

    Article • The Journal of Infectious Diseases, January 1979, Oxford University Press (OUP)

    Dr David R Snydman

  228. Sputum: a diagnostic pitfall in alcoholics

    Article • Archives of Internal Medicine, December 1978, American Medical Association (AMA)

    Dr David R Snydman

  229. Sputum

    Article • Archives of Internal Medicine, December 1978, American Medical Association (AMA)

    Dr David R Snydman

  230. An epidemic of oligoarticular arthritis in children and adults in three connecticut communities

    Article • Arthritis & Rheumatism, January 1977, Wiley

    Dr David R Snydman

  231. Transmission of Hepatitis B Associated with Hemodialysis: Role of Malfunction (Blood Leaks) in Dialysis Machines

    Article • The Journal of Infectious Diseases, December 1976, Oxford University Press (OUP)

    Dr David R Snydman

  232. Nosocomial Viral Hepatitis B

    Article • Annals of Internal Medicine, November 1976, American College of Physicians

    Dr David R Snydman

  233. Hepatitis B infection from medical personnel

    Article • JAMA, August 1976, American Medical Association (AMA)

    Dr David R Snydman

  234. Hepatitis B Infection From Medical Personnel

    Article • JAMA, August 1976, American Medical Association (AMA)

    Dr David R Snydman

  235. Prevention of Nosocomial Viral Hepatitis, Type B (Hepatitis B)

    Article • Annals of Internal Medicine, December 1975, American College of Physicians

    Dr David R Snydman

  236. Thin-layer chromatography of citric acid cycle intermediates, pyruvate and lactate

    Article • Journal of Chromatography A, January 1968, Elsevier

    Dr David R Snydman